Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
AI in Ultrasound Imaging Market: 30% CAGR to $18.6B by 2033
Artificial Intelligence in Ultrasound Imaging Market
AI in Ultrasound Imaging Market: 30% CAGR to $18.6B by 2033
Artificial Intelligence in Ultrasound Imaging Market by Technology (Machine Learning, Computer Vision, Natural Language Processing, Context-Aware Computing), by Application (Radiology, Obstetrics, Gynecology, Cardiovascular, Gastroenterology), by End User (Hospitals and Providers, Patients, Pharmaceutical, Biotechnology Companies, Healthcare Payers), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
Updated On : Oct 3, 2026|Base Year : 2025|Pages : 0
The Artificial Intelligence in Ultrasound Imaging Market has shifted from pilot deployments to contracted, recurring software revenue. Valuation rises from USD 1.75 billion in 2024 to USD 18.56 billion by 2033, a 30.0% CAGR that exceeds every other medical imaging AI vertical tracked in this database.
Artificial Intelligence in Ultrasound Imaging Market Size (In Billion)
15.0B
10.0B
5.0B
0
2.275 B
2025
2.958 B
2026
3.845 B
2027
4.998 B
2028
6.498 B
2029
8.447 B
2030
10.98 B
2031
Three structural facts define the current cycle:
Reimbursement clarity is the gating factor. Roughly 1,100 FDA-cleared AI imaging devices existed by mid-2025; ultrasound-linked clearances represent about 9% of that total but a notably higher share of new point-of-care submissions.
Installed-base economics beat new-unit economics. Software attach rates on premium cart-based systems reached an estimated 34% in North America in 2024, versus 12% in 2021.
Deployment is moving to the edge. On-device inference removed cloud latency and bandwidth penalties, which is why the Point-of-Care Ultrasound Devices Market shipped an estimated 1.4 million handheld and compact units in 2024.
Where Value Concentrates
The Machine Learning Ultrasound Software Market accounted for roughly USD 640 million of 2024 value, or 37% of total AI ultrasound software spend.
Subscription and per-scan licensing now represent 61% of software revenue, up from 29% in 2020, compressing near-term bookings while lifting renewal value.
Cardiology and obstetrics workflows hold the highest willingness-to-pay because measurement error carries visible clinical and legal consequences.
Risk Read-Out
Regulatory reclassification of autonomous diagnostic claims could add 6-14 months to launch timelines in the United States and the European Union.
Edge-AI silicon cost remains 11-18% of handheld device bill-of-materials, exposing margins to allocation cycles.
Only 5 vendors control more than 48% of the AI-capable ultrasound installed base, concentrating pricing power.
Bottom line: growth is volume-supported but software-priced. Attach rate and renewal revenue matter more than scanner shipments when assessing this market.
Segment Deep-Dive: Radiology Application Dominance in Artificial Intelligence in Ultrasound Imaging Market
Segment Analysis Matrix
Segment
CAGR (%)
Market Share (%)
Key Demand Driver
Radiology
32.5%
34%
High-volume triage of abdominal and thyroid exams with PACS-integrated worklists
Cardiovascular
29.4%
22%
Automated ejection-fraction and strain quantification in echocardiography labs
Obstetrics & Gynecology
27.8%
18%
Fetal biometry automation and midwife-operated scanning programs
Why Radiology Leads
Radiology carries the highest exam volume per installed system and the cleanest label supply for supervised training; roughly 4.1 billion diagnostic ultrasound exams are performed worldwide each year.
The AI Radiology Diagnostics Market expands because payers accept narrow, measurable claims such as lesion measurement variance and report turnaround time more readily than broad diagnostic claims.
The Computer Vision Medical Imaging Market supplies the core architecture for frame-level segmentation, measurement calipers, and image-quality gating used across all three leading application segments.
Sub-Segment Dynamics
Within technology, machine learning dominates deployed models, but computer vision pipelines absorb about 58% of inference compute time because preprocessing and segmentation run on every frame.
Context-aware computing remains the smallest technology sub-segment at under 6% of revenue, yet it advances fastest in obstetrics, where workflow state determines which measurement is auto-populated.
Natural language processing is monetized indirectly, embedded in report generation rather than sold as a stand-alone license.
Obstetrics Traction
The Obstetric Ultrasound Imaging Market is the most defensible niche: over 140 million births annually create recurring, non-discretionary scanning demand, and midwifery-led systems in the United Kingdom, the Nordics, and parts of India treat semi-automated biometry as a staffing substitute rather than a convenience feature.
Margin Pressures
Gross margins on AI software sit at 72-80%, but effective margins fall to 38-46% after regulatory maintenance, clinical validation, and integration services.
OEM bundling is the primary margin risk: when AI is folded into a scanner list price, stand-alone vendors lose 20-30% of achievable per-unit pricing.
Hardware-side pressure is structural, with compact system ASPs declining 2-4% annually since 2021; vendors counter through software renewal terms of 3-5 years.
Primary Market Drivers & Growth Restraints in Artificial Intelligence in Ultrasound Imaging Market
Market Dynamics Impact Analysis
Factor Type
Description
Impact Level
Timeline
Driver
Sonographer shortage, with vacancy rates of 12-18% across US and UK health systems, forces workflow automation
High
Short term
Driver
FDA CDRH ultrasound AI clearance volume rising approximately 19% year over year
High
Short term
Driver
Reimbursement codes for AI-assisted image analysis in major payer markets
High
Long term
Driver
Edge inference pushing cost per processed scan below USD 0.40
Medium
Short term
Restraint
Lifecycle validation burden of USD 1.2-3.5 million per cleared model
High
Long term
Restraint
Data access fragmentation across PACS vendors and differing national privacy regimes
High
Long term
Restraint
Edge-AI silicon allocation consuming 11-18% of handheld bill-of-materials
Medium
Short term
Restraint
Clinician trust and liability ambiguity in autonomous measurement claims
Medium
Long term
Catalyst Read-Out
The Healthcare AI Semiconductor Market supplies the inference substrate for this category, and its capacity additions directly govern how quickly ultrasound vendors can ship embedded models. Each 1 percentage point gain in software attach rate across the installed base adds an estimated USD 95-120 million in annual recurring revenue at 2024 pricing. Regulatory momentum reinforces the trend: jurisdictional clearances for ultrasound-linked algorithms rose roughly 19% year over year through 2025.
Bottleneck Read-Out
The EU AI Act high-risk classification imposes documentation and post-market surveillance obligations that add 9-15% to compliance cost for vendors selling into the bloc.
Hospital capital committee cycles run 9-18 months, delaying revenue recognition even after regulatory clearance is secured.
Label scarcity in rare indications means some cleared models reach market with training sets under 5,000 annotated studies, which slows payer acceptance.
Integrated cart-based AI workflow and imaging informatics
Hospital radiology and cardiology
Leader
General Electric
Installed-base scale and broad point-of-care portfolio
Health systems, emergency medicine
Leader
NVIDIA Corporation
Inference silicon and medical imaging SDKs
OEMs and software developers
Leader (enabling layer)
SAMSUNG
Compact and handheld system integration
Ambulatory and OB/GYN clinics
Challenger
EchoNous
Probe-level inference for point-of-care scanning
Emergency and primary care
Challenger
General Vision Inc.
Pattern-recognition IP licensing
OEM engineering teams
Niche
Precision Health AI
Validated clinical datasets and evidence generation
Pharma and research sponsors
Niche
IBM
Hybrid cloud and imaging data governance
Enterprise health systems
Challenger
Koninklijke Philips N.V.: anchors the premium cart segment and pairs AI measurement tools with informatics contracts, giving it the strongest renewal economics in the category.
General Electric: leverages its installed base to convert scanner refresh cycles into bundled AI licenses across cardiology and emergency departments.
NVIDIA Corporation: monetizes the enabling layer rather than clinical claims, positioning its inference silicon inside most competing ultrasound platforms.
SAMSUNG: competes on price-performance in compact and handheld systems, particularly across Asian and Middle Eastern ambulatory markets.
EchoNous: targets emergency and primary care with low-cost, probe-integrated inference and a hardware-as-a-service commercial model.
General Vision Inc.: licenses recognition IP to OEM engineering teams, avoiding regulatory exposure tied to diagnostic claims.
Precision Health AI: supplies curated, protocol-standardized datasets to pharmaceutical sponsors running imaging-endpoint trials.
IBM: sells governance, de-identification, and hybrid cloud infrastructure that health systems require before deploying imaging models.
Strategic Milestones & Recent Developments in Artificial Intelligence in Ultrasound Imaging Market
Latest Strategic Moves
Date
Company
Event Type
Impact
Q1 2025
Koninklijke Philips N.V.
Launch
Expanded cardiology AI module across premium cart platforms
Q4 2024
NVIDIA Corporation
Partnership
Embedded inference toolkit adoption across handheld OEMs
Q3 2024
General Electric
Launch
Automated fetal biometry release targeting midwifery-led systems
Q2 2024
EchoNous
Partnership
Primary care distribution agreement covering North America
Q1 2024
SAMSUNG
Launch
On-device measurement suite for compact portable systems
Q3 2023
Microsoft
Partnership
Azure-based imaging pipeline for multi-site clinical validation
Q1 2025 - Koninklijke Philips N.V. launched an expanded cardiology module, extending AI-assisted strain and ejection-fraction measurement into routine echocardiography workflows.
Q4 2024 - NVIDIA Corporation broadened its medical imaging toolkit partnership model, which accelerated embedded model deployment timelines for handheld device makers by an estimated 4-7 months.
Q3 2024 - General Electric released automated fetal biometry tools aimed at markets with midwifery-led scanning, widening the addressable buyer set beyond radiologists.
Q2 2024 - EchoNous signed a primary care distribution agreement, moving point-of-care AI from hospital pilots toward outpatient reimbursement pathways.
Q1 2024 - SAMSUNG shipped an on-device measurement suite, reinforcing the shift from cloud inference to local processing.
The Clinical Decision Support Software Market increasingly determines how these launches are evaluated, because buyers now assess integration with existing reporting systems rather than algorithm features in isolation.
Regional Market Analysis & Growth Corridors for Artificial Intelligence in Ultrasound Imaging Market
Regional Growth Comparison
Region
Projected CAGR (%)
Base Year Valuation
Primary Catalyst
Regulatory Stringency
North America
28.4%
USD 0.66 billion
Payer coverage expansion and hospital consolidation
High
Europe
26.1%
USD 0.42 billion
EU AI Act conformity and public procurement frameworks
High
Asia-Pacific
35.2%
USD 0.47 billion
Volume scanning demand and domestic OEM scale
Medium to High
LAMEA
24.5%
USD 0.19 billion
Private hospital investment and teleradiology expansion
Medium
Fastest-Growing Region
Asia-Pacific grows at 35.2%, the highest of any region, driven by domestic system builders in China, South Korea, and India that bundle AI measurement tools at aggressive price points.
Government screening programs and rapid private hospital construction raise unit volumes faster than reimbursement matures, so revenue growth leads margin growth in this region.
Most Mature Markets
North America holds 38% of global value at USD 0.66 billion in 2024, supported by payer infrastructure and consolidated health systems that can absorb validation costs.
Europe advances at 26.1%, constrained less by demand than by conformity assessment timelines under the EU AI Act; German and Nordic health systems remain the earliest adopters.
LAMEA is the smallest region at USD 0.19 billion but posts 24.5% growth as private operators in the GCC and Turkey deploy portable systems with embedded measurement.
The Digital Health Diagnostics Market acts as the connective layer in every region, since payer acceptance of AI ultrasound claims increasingly depends on how findings flow into longitudinal diagnostic records rather than how the model performs in isolation.
Growth Corridors to Watch
China and India account for the majority of new handheld unit shipments, while the United States and Germany lead in software attach revenue per unit.
Teleradiology linkups between Gulf hospitals and European reading centers create a distinct cross-border demand channel for AI-assisted ultrasound triage.
Supply Chain & Raw Material Dynamics: Artificial Intelligence in Ultrasound Imaging Market
Upstream Input Risk Matrix
Input
Dependency
Price Trend
Risk Level
Piezoelectric ceramics (PZT)
Concentrated in Japan and Germany
Up 6-9% since 2023
High
PMN-PT single crystal
Limited number of qualified growers
Up 11-14% since 2022
High
Edge-AI SoC and GPU modules
Fabrication constrained at leading nodes
Flat to up 3%
Medium
Analog front-end chips
Multi-source, mature node
Down 2-5%
Low
Annotated clinical datasets
Hospital partnerships and IRB access
Up 15-22% per frame
High
Upstream Dependencies
The Medical Ultrasound Transducer Market depends on lead zirconate titanate ceramics, where lead oxide, zirconium oxide, and titanium dioxide feedstock pricing and RoHS exemption reviews create recurring sourcing uncertainty.
Silicon supply is less volatile but more concentrated: a single fabrication node shift can delay embedded inference deployment across multiple OEM product lines.
Historical Disruptions
The 2020-2022 semiconductor shortage pushed ultrasound lead times beyond 26 weeks, forcing OEMs to redesign boards around available analog components.
A 2021 piezoelectric capacity constraint raised transducer costs by an estimated 8%, an increase largely absorbed rather than passed to buyers.
Annotation labor became the binding constraint after 2023, with clinical dataset costs now representing 12-19% of total model development spend.
Export, Cross-Border Trade & Tariff Impact on Artificial Intelligence in Ultrasound Imaging Market
Trade Corridor Overview
Corridor
Dominant Flow
Approximate Scale
Principal Barrier
United States to global
Finished systems and software licenses
USD 2.1 billion (2023 exports)
Export licensing for advanced imaging modules
Germany and Netherlands to global
Premium cart systems
Combined top-3 exporter position
EU conformity assessment timelines
China to emerging markets
Compact and handheld units
Rising share of mid-range volume
Section 301 tariff of 25% in the United States
Japan to Asia-Pacific
Transducer components and precision parts
Stable, high-value component flow
Yen-driven price volatility
Trade Policy Impact
Section 301 tariffs of 25% on Chinese-origin ultrasound systems, paired with Chinese domestic procurement preferences, redirected a measurable share of mid-range volume toward local suppliers between 2022 and 2025.
India applies import duties of 7.5-10% on ultrasound scanners, which favors local assembly and inflates landed cost for imported premium systems.
Non-Tariff Barriers
Data-localization requirements in China, Russia, and India restrict transfer of annotated imaging datasets, effectively forcing regional model training and duplicating validation cost.
Cross-border digital services taxation on software subscriptions adds 2-7% to effective licensing cost in several jurisdictions.
Registration and re-validation requirements for AI modules mean a single model may require 3-5 separate national approvals before regional scale is achievable.
Outlook
Trade policy affects hardware flow moderately but affects training data flow severely, which is why vendors increasingly build regional inference models rather than one global model per clinical indication.
Artificial Intelligence in Ultrasound Imaging Market Segmentation
1. Technology
1.1. Machine Learning
1.2. Computer Vision
1.3. Natural Language Processing
1.4. Context-Aware Computing
2. Application
2.1. Radiology
2.2. Obstetrics
2.3. Gynecology
2.4. Cardiovascular
2.5. Gastroenterology
3. End User
3.1. Hospitals and Providers
3.2. Patients
3.3. Pharmaceutical
3.4. Biotechnology Companies
3.5. Healthcare Payers
Artificial Intelligence in Ultrasound Imaging Market Segmentation By Geography
1. North America
1.1. United States
1.2. Canada
1.3. Mexico
2. South America
2.1. Brazil
2.2. Argentina
2.3. Rest of South America
3. Europe
3.1. United Kingdom
3.2. Germany
3.3. France
3.4. Italy
3.5. Spain
3.6. Russia
3.7. Benelux
3.8. Nordics
3.9. Rest of Europe
4. Middle East & Africa
4.1. Turkey
4.2. Israel
4.3. GCC
4.4. North Africa
4.5. South Africa
4.6. Rest of Middle East & Africa
5. Asia Pacific
5.1. China
5.2. India
5.3. Japan
5.4. South Korea
5.5. ASEAN
5.6. Oceania
5.7. Rest of Asia Pacific
Artificial Intelligence in Ultrasound Imaging Market REPORT HIGHLIGHTS
Aspects
Details
Study Period
2020-2034
Base Year
2025
Estimated Year
2026
Forecast Period
2026-2034
Historical Period
2020-2025
Growth Rate
CAGR of 30% from 2020-2034
Segmentation
By Technology
Machine Learning
Computer Vision
Natural Language Processing
Context-Aware Computing
By Application
Radiology
Obstetrics
Gynecology
Cardiovascular
Gastroenterology
By End User
Hospitals and Providers
Patients
Pharmaceutical
Biotechnology Companies
Healthcare Payers
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
United Kingdom
Germany
France
Italy
Spain
Russia
Benelux
Nordics
Rest of Europe
Middle East & Africa
Turkey
Israel
GCC
North Africa
South Africa
Rest of Middle East & Africa
Asia Pacific
China
India
Japan
South Korea
ASEAN
Oceania
Rest of Asia Pacific
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objective
1.4. Definitions and Assumptions
2. Executive Summary
2.1. Market Snapshot
3. Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Trends
3.4. Market Opportunity
4. Market Factor Analysis
4.1. Porters Five Forces
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL analysis
4.3. BCG Analysis
4.3.1. Stars (High Growth, High Market Share)
4.3.2. Cash Cows (Low Growth, High Market Share)
4.3.3. Question Mark (High Growth, Low Market Share)
4.3.4. Dogs (Low Growth, Low Market Share)
4.4. Ansoff Matrix Analysis
4.5. Supply Chain Analysis
4.6. Regulatory Landscape
4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
4.8. MIQ Analyst Note
5. Market Analysis, Insights and Forecast, 2020-2034
5.1. Market Analysis, Insights and Forecast - by Technology
5.1.1. Machine Learning
5.1.2. Computer Vision
5.1.3. Natural Language Processing
5.1.4. Context-Aware Computing
5.2. Market Analysis, Insights and Forecast - by Application
5.2.1. Radiology
5.2.2. Obstetrics
5.2.3. Gynecology
5.2.4. Cardiovascular
5.2.5. Gastroenterology
5.3. Market Analysis, Insights and Forecast - by End User
5.3.1. Hospitals and Providers
5.3.2. Patients
5.3.3. Pharmaceutical
5.3.4. Biotechnology Companies
5.3.5. Healthcare Payers
5.4. Market Analysis, Insights and Forecast - by Region
5.4.1. North America
5.4.2. South America
5.4.3. Europe
5.4.4. Middle East & Africa
5.4.5. Asia Pacific
6. North America Market Analysis, Insights and Forecast, 2020-2034
6.1. Market Analysis, Insights and Forecast - by Technology
6.1.1. Machine Learning
6.1.2. Computer Vision
6.1.3. Natural Language Processing
6.1.4. Context-Aware Computing
6.2. Market Analysis, Insights and Forecast - by Application
6.2.1. Radiology
6.2.2. Obstetrics
6.2.3. Gynecology
6.2.4. Cardiovascular
6.2.5. Gastroenterology
6.3. Market Analysis, Insights and Forecast - by End User
6.3.1. Hospitals and Providers
6.3.2. Patients
6.3.3. Pharmaceutical
6.3.4. Biotechnology Companies
6.3.5. Healthcare Payers
7. South America Market Analysis, Insights and Forecast, 2020-2034
7.1. Market Analysis, Insights and Forecast - by Technology
7.1.1. Machine Learning
7.1.2. Computer Vision
7.1.3. Natural Language Processing
7.1.4. Context-Aware Computing
7.2. Market Analysis, Insights and Forecast - by Application
7.2.1. Radiology
7.2.2. Obstetrics
7.2.3. Gynecology
7.2.4. Cardiovascular
7.2.5. Gastroenterology
7.3. Market Analysis, Insights and Forecast - by End User
7.3.1. Hospitals and Providers
7.3.2. Patients
7.3.3. Pharmaceutical
7.3.4. Biotechnology Companies
7.3.5. Healthcare Payers
8. Europe Market Analysis, Insights and Forecast, 2020-2034
8.1. Market Analysis, Insights and Forecast - by Technology
8.1.1. Machine Learning
8.1.2. Computer Vision
8.1.3. Natural Language Processing
8.1.4. Context-Aware Computing
8.2. Market Analysis, Insights and Forecast - by Application
8.2.1. Radiology
8.2.2. Obstetrics
8.2.3. Gynecology
8.2.4. Cardiovascular
8.2.5. Gastroenterology
8.3. Market Analysis, Insights and Forecast - by End User
8.3.1. Hospitals and Providers
8.3.2. Patients
8.3.3. Pharmaceutical
8.3.4. Biotechnology Companies
8.3.5. Healthcare Payers
9. Middle East & Africa Market Analysis, Insights and Forecast, 2020-2034
9.1. Market Analysis, Insights and Forecast - by Technology
9.1.1. Machine Learning
9.1.2. Computer Vision
9.1.3. Natural Language Processing
9.1.4. Context-Aware Computing
9.2. Market Analysis, Insights and Forecast - by Application
9.2.1. Radiology
9.2.2. Obstetrics
9.2.3. Gynecology
9.2.4. Cardiovascular
9.2.5. Gastroenterology
9.3. Market Analysis, Insights and Forecast - by End User
9.3.1. Hospitals and Providers
9.3.2. Patients
9.3.3. Pharmaceutical
9.3.4. Biotechnology Companies
9.3.5. Healthcare Payers
10. Asia Pacific Market Analysis, Insights and Forecast, 2020-2034
10.1. Market Analysis, Insights and Forecast - by Technology
10.1.1. Machine Learning
10.1.2. Computer Vision
10.1.3. Natural Language Processing
10.1.4. Context-Aware Computing
10.2. Market Analysis, Insights and Forecast - by Application
10.2.1. Radiology
10.2.2. Obstetrics
10.2.3. Gynecology
10.2.4. Cardiovascular
10.2.5. Gastroenterology
10.3. Market Analysis, Insights and Forecast - by End User
10.3.1. Hospitals and Providers
10.3.2. Patients
10.3.3. Pharmaceutical
10.3.4. Biotechnology Companies
10.3.5. Healthcare Payers
11. Competitive Analysis
11.1. Company Profiles
11.1.1. General Vision Inc.
11.1.1.1. Company Overview
11.1.1.2. Products
11.1.1.3. Company Financials
11.1.1.4. SWOT Analysis
11.1.2. EchoNous
11.1.2.1. Company Overview
11.1.2.2. Products
11.1.2.3. Company Financials
11.1.2.4. SWOT Analysis
11.1.3. Inc.
11.1.3.1. Company Overview
11.1.3.2. Products
11.1.3.3. Company Financials
11.1.3.4. SWOT Analysis
11.1.4. Johnson & Johnson Services
11.1.4.1. Company Overview
11.1.4.2. Products
11.1.4.3. Company Financials
11.1.4.4. SWOT Analysis
11.1.5. Inc.
11.1.5.1. Company Overview
11.1.5.2. Products
11.1.5.3. Company Financials
11.1.5.4. SWOT Analysis
11.1.6. Intel Corporation
11.1.6.1. Company Overview
11.1.6.2. Products
11.1.6.3. Company Financials
11.1.6.4. SWOT Analysis
11.1.7. NVIDIA Corporation
11.1.7.1. Company Overview
11.1.7.2. Products
11.1.7.3. Company Financials
11.1.7.4. SWOT Analysis
11.1.8. Koninklijke Philips N.V.
11.1.8.1. Company Overview
11.1.8.2. Products
11.1.8.3. Company Financials
11.1.8.4. SWOT Analysis
11.1.9. Microsoft
11.1.9.1. Company Overview
11.1.9.2. Products
11.1.9.3. Company Financials
11.1.9.4. SWOT Analysis
11.1.10. IBM
11.1.10.1. Company Overview
11.1.10.2. Products
11.1.10.3. Company Financials
11.1.10.4. SWOT Analysis
11.1.11. General Electric
11.1.11.1. Company Overview
11.1.11.2. Products
11.1.11.3. Company Financials
11.1.11.4. SWOT Analysis
11.1.12. SAMSUNG
11.1.12.1. Company Overview
11.1.12.2. Products
11.1.12.3. Company Financials
11.1.12.4. SWOT Analysis
11.1.13. Precision Health AI
11.1.13.1. Company Overview
11.1.13.2. Products
11.1.13.3. Company Financials
11.1.13.4. SWOT Analysis
11.1.14. Welcome AI
11.1.14.1. Company Overview
11.1.14.2. Products
11.1.14.3. Company Financials
11.1.14.4. SWOT Analysis
11.2. Market Entropy
11.2.1. Company's Key Areas Served
11.2.2. Recent Developments
11.3. Company Market Share Analysis, 2026
11.3.1. Top 5 Companies Market Share Analysis
11.3.2. Top 3 Companies Market Share Analysis
11.4. List of Potential Customers
12. Research Methodology
List of Figures
Figure 1: Artificial Intelligence in Ultrasound Imaging Market Revenue Breakdown (billion, %) by Region 2026 & 2034
Figure 2: North America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Technology 2026 & 2034
Figure 3: North America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Technology 2026 & 2034
Figure 4: North America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Application 2026 & 2034
Figure 5: North America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Application 2026 & 2034
Figure 6: North America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by End User 2026 & 2034
Figure 7: North America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by End User 2026 & 2034
Figure 8: North America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Country 2026 & 2034
Figure 9: North America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Country 2026 & 2034
Figure 10: South America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Technology 2026 & 2034
Figure 11: South America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Technology 2026 & 2034
Figure 12: South America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Application 2026 & 2034
Figure 13: South America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Application 2026 & 2034
Figure 14: South America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by End User 2026 & 2034
Figure 15: South America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by End User 2026 & 2034
Figure 16: South America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Country 2026 & 2034
Figure 17: South America Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Country 2026 & 2034
Figure 18: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Technology 2026 & 2034
Figure 19: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Technology 2026 & 2034
Figure 20: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Application 2026 & 2034
Figure 21: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Application 2026 & 2034
Figure 22: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by End User 2026 & 2034
Figure 23: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by End User 2026 & 2034
Figure 24: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Country 2026 & 2034
Figure 25: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Country 2026 & 2034
Figure 26: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Technology 2026 & 2034
Figure 27: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Technology 2026 & 2034
Figure 28: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Application 2026 & 2034
Figure 29: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Application 2026 & 2034
Figure 30: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by End User 2026 & 2034
Figure 31: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by End User 2026 & 2034
Figure 32: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Country 2026 & 2034
Figure 33: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Country 2026 & 2034
Figure 34: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Technology 2026 & 2034
Figure 35: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Technology 2026 & 2034
Figure 36: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Application 2026 & 2034
Figure 37: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Application 2026 & 2034
Figure 38: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by End User 2026 & 2034
Figure 39: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by End User 2026 & 2034
Figure 40: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue (billion), by Country 2026 & 2034
Figure 41: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue Share (%), by Country 2026 & 2034
List of Tables
Table 1: Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Technology 2020 & 2034
Table 2: Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Application 2020 & 2034
Table 3: Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by End User 2020 & 2034
Table 4: Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Region 2020 & 2034
Table 5: North America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Technology 2020 & 2034
Table 6: North America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Application 2020 & 2034
Table 7: North America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by End User 2020 & 2034
Table 8: North America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Country 2020 & 2034
Table 9: United States Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 10: Canada Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 11: Mexico Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 12: South America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Technology 2020 & 2034
Table 13: South America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Application 2020 & 2034
Table 14: South America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by End User 2020 & 2034
Table 15: South America Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Country 2020 & 2034
Table 16: Brazil Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 17: Argentina Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 18: Rest of South America Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 19: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Technology 2020 & 2034
Table 20: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Application 2020 & 2034
Table 21: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by End User 2020 & 2034
Table 22: Europe Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Country 2020 & 2034
Table 23: United Kingdom Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 24: Germany Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 25: France Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 26: Italy Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 27: Spain Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 28: Russia Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 29: Benelux Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 30: Nordics Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 31: Rest of Europe Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 32: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Technology 2020 & 2034
Table 33: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Application 2020 & 2034
Table 34: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by End User 2020 & 2034
Table 35: Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Country 2020 & 2034
Table 36: Turkey Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 37: Israel Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 38: GCC Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 39: North Africa Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 40: South Africa Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 41: Rest of Middle East & Africa Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 42: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Technology 2020 & 2034
Table 43: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Application 2020 & 2034
Table 44: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by End User 2020 & 2034
Table 45: Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue billion Forecast, by Country 2020 & 2034
Table 46: China Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 47: India Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 48: Japan Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 49: South Korea Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 50: ASEAN Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 51: Oceania Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Table 52: Rest of Asia Pacific Artificial Intelligence in Ultrasound Imaging Market Revenue (billion) Forecast, by Application 2020 & 2034
Research Methodology & Data Sources
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
Primary Research
Primary research accounts for 70-80% of total project effort, with the remaining 20-30% covered by secondary and benchmark sources.
We conducted 1,240 structured interviews and surveys across 22 countries between Q3 2025 and Q1 2026, targeting the exact value chain for AI-enabled ultrasound.
Company types interviewed: AI inference software developers building deep-learning ultrasound reconstruction and measurement pipelines; handheld and point-of-care ultrasound OEMs integrating on-device neural inference; GPU and edge-AI system-on-chip suppliers selling into ultrasound beamforming and post-processing; piezoelectric transducer material suppliers of PZT and PMN-PT single crystal; and PACS and radiology informatics vendors embedding clinical decision support software.
Stakeholder job titles interviewed: Director of Ultrasound Imaging Informatics; Chief of Maternal-Fetal Medicine; Vice President of Clinical AI Product Management; Hospital Capital Equipment Procurement Manager.
Interview guides covered attach-rate economics, validation cost, reimbursement pathways, and cross-border data constraints, with verbatim pricing data captured for per-probe subscription tiers.
Key Stakeholders Interviewed
Stakeholder Role
Interview Share (%)
Director of Ultrasound Imaging Informatics
30%
Vice President of Clinical AI Product Management
26%
Chief of Maternal-Fetal Medicine
24%
Hospital Capital Equipment Procurement Manager
20%
Industry Ecosystem Breakdown
Company Type
Representation (%)
AI Ultrasound Software Developers
28%
Ultrasound Hardware OEMs
24%
Edge AI and GPU Semiconductor Suppliers
16%
Hospital Imaging Procurement Groups
20%
Regulatory and Standards Consultants
12%
Secondary Research & Industry Benchmarking
Secondary research draws on audited financial filings, corporate disclosures, and standard financial databases: Bloomberg, Factiva, Hoovers, and PitchBook.
No commercial market research aggregator websites are used as inputs; every benchmark is traceable to a primary filing, regulator, or peer-reviewed publication.
All datasets, base-year figures, and forecasts are refreshed to the date of purchase, so buyers receive the current market position rather than a locked snapshot.
Demand Modeling & Market Estimation
Top-down and bottom-up models are constructed simultaneously and reconciled through multi-level data triangulation across technology, application, end-user, and country dimensions.
Bottom-up sizing uses specific quantitative metrics: annual ultrasound examinations per 1,000 population by care setting; installed base of ultrasound systems segmented by cart-based, compact, and handheld form factors; AI software attach rate per installed unit; average annual software subscription price per probe; and annual handheld point-of-care unit shipment volumes.
Top-down sizing begins from global medical imaging spend and applies ultrasound modality share, then layers AI-enabled revenue conversion rates derived from vendor disclosures.
Regional estimates are validated against national health expenditure data and procedure-volume registries, with country-level variance capped at 4% against regional aggregates.
Segment forecasts are built on independent growth curves rather than a single blended rate, reflecting materially different adoption speeds across radiology, cardiovascular, and obstetric workflows.
Data Accuracy & Quality Check
Estimated data accuracy is guaranteed at 85-90%, supported by three independent validation layers: interview cross-verification, filing reconciliation, and regression testing of forecast curves against historical adoption patterns.
Confidence intervals are reported at 95%, with a typical margin of plus or minus 4.2% on headline valuations.
Any data point sourced from fewer than three independent respondents is flagged as low-confidence and excluded from headline totals.
Contradictions between primary interviews and secondary filings are escalated to a senior analyst review before inclusion.
Final deliverables are re-validated and updated to the date of purchase, including any interim regulatory or pricing changes affecting the reported base year.
Frequently Asked Questions
1. How are purchasing behaviors and buyer expectations shifting in the Artificial Intelligence in Ultrasound Imaging Market?
Buyers have moved from one-off capital purchases toward 3 to 5 year software subscriptions bundled with scanner refresh cycles. In 2024, recurring and per-scan licensing represented 61% of AI ultrasound software revenue, up from 29% in 2020. Procurement committees now weigh measured turnaround-time gains and sonographer hours saved rather than raw algorithm accuracy scores. Roughly 34% of premium cart-based systems shipped in North America in 2024 carried an activated AI module.
2. What is the current market size and expected CAGR through 2033?
The Artificial Intelligence in Ultrasound Imaging Market was valued at USD 1.75 billion in 2024 and is projected to reach USD 18.56 billion by 2033. That trajectory implies a 30.0% compound annual growth rate over the 2025 to 2033 forecast window. Asia-Pacific grows fastest at 35.2%, while North America holds the largest revenue base at roughly 38% of global value. Software renewal revenue, not new scanner shipments, drives most of the incremental expansion.
3. How are pricing trends and cost structures evolving?
Per-probe AI software subscriptions typically range from USD 3,000 to USD 12,000 annually depending on the clinical module and system tier. Gross margins on stand-alone AI software sit between 72% and 80%, but fall to 38% to 46% after clinical validation, regulatory maintenance, and integration services. Hardware ASPs for compact and handheld ultrasound units have declined 2% to 4% per year since 2021, pushing vendors to defend value through software contract duration. GPU and edge-AI silicon consumes 11% to 18% of handheld device bill-of-materials cost.
4. Why did post-pandemic recovery reshape the market structurally?
Scanning volumes rebounded sharply after 2021, and AI module attach rates rose from 12% in 2021 to 34% in 2024 as hospitals rebuilt imaging capacity. The pandemic accelerated remote and teleradiology workflows, which made cloud-linked inference acceptable to infection-control and IT teams that previously blocked it. Structural change also appeared on the supply side, where component shortages pushed OEMs to dual-source transducers and edge processors. Capital budget cycles shortened from 18 months to 12 months in several European health systems.
5. Who are the leading companies and how concentrated is the competitive landscape?
Koninklijke Philips N.V., General Electric, and SAMSUNG dominate the AI-capable ultrasound installed base, while NVIDIA Corporation supplies inference silicon across most competing platforms. Five vendors control more than 48% of the AI-enabled installed base, which concentrates pricing power but narrows channel choice for hospitals. Handheld-focused challengers such as EchoNous compete on probe-level inference and lower deployment cost. Niche players including General Vision Inc. and Precision Health AI monetize licensing and validated clinical datasets rather than end-user systems.
6. What do export-import dynamics and trade policy mean for cross-border shipments?
US-origin ultrasound system exports were valued at approximately USD 2.1 billion in 2023, with Germany, the Netherlands, and Japan acting as other net exporters of finished systems. Section 301 tariffs of 25% on Chinese-origin ultrasound equipment, matched by domestic procurement preferences in China, diverted a measurable share of mid-range volume. India applies import duties of 7.5% to 10% on ultrasound scanners, while data-localization rules in China, Russia, and India restrict cross-border transfer of annotated imaging datasets used for model training.
.jpg){kind=small}
